Michael C. Perry

19.4k citations
198 papers · 14.6k · 3 hit papers · h-index 45

Impact in

  • Oncology top 0.1%
    • Lung Cancer Research Studies
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

Michael C. Perry

193 papers receiving 14.1k citations

Michael C. Perry's Hit Papers

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer 2006 · 4.5k citations
4.5k0+12+24Years since publication10002.0k3.0k4.0k

Peers

Michael C. Perry
Comparison fields: 5 of 171
  • Oncology 6.2k
  • Pulmonary and Respiratory Medicine 5.6k
  • Cancer Research 1.3k
  • Hepatology 422
  • Internal Medicine 176
Replace Valter Torri with:
Valter Torri Italy
Stefano Cascinu Italy
Shaker R. Dakhil United States
Douglass C. Tormey United States
Satoshi Morita Japan
Hans‐Joachim Schmoll Germany
Martin H. Cohen United States
Sandro Barni Italy
Muhammad Wasif Saif United States
Egbert F. Smit Netherlands
Michael C. Perry relative to Valter Torri Italy Valter Torri's profile →
Citations per field
00.5×1.5×
Valter Torri · 1×
Citations per year

Countries citing papers authored by Michael C. Perry

Since Specialization
Citations

This map shows the geographic impact of Michael C. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Perry more than expected).

Fields of papers citing papers by Michael C. Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Perry. The network helps show where Michael C. Perry may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael C. Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael C. Perry Line = papers co-authored together Michael C. Perry links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Hit paper breakdown →
20064500
2
A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
Hit paper breakdown →
1992935
3
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
Hit paper breakdown →
1990880
4 1987357
5 2004351
6 2001333
7 2000299
8 2002286
9
American Society of Clinical Oncology educational book
2003286
10 2005276
11 2005271
12
Plasma microRNAs as novel biomarkers for early detection of lung cancer.
2011217
13 2004215
14 2001209
15 2001189
16 2006187
17 1991184
18 2007175
19 2003175
20 1989167

About Michael C. Perry

Michael C. Perry is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Pathology and Forensic Medicine, having authored 198 papers that have together received 14.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (36 papers), Lung Cancer Research Studies (35 papers), Cancer Treatment and Pharmacology (22 papers), Neuroendocrine Tumor Research Advances (21 papers), Lung Cancer Diagnosis and Treatment (16 papers), Cancer therapeutics and mechanisms (16 papers), Lymphoma Diagnosis and Treatment (9 papers) and Breast Cancer Treatment Studies (8 papers). The work is most often cited by research in Oncology (6.2k citations), Pulmonary and Respiratory Medicine (5.6k citations), Cancer Research (1.3k citations), Hepatology (422 citations) and Internal Medicine (176 citations). Michael C. Perry has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include David H. Johnson, Joan H. Schiller, Julie R. Brahmer, Afshin Dowlati, Robert J. Gray, Rogério Lilenbaum, Alan Sandler, Mark R. Green, Paul D. King and Walter L. Eaton. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Cancer, New England Journal of Medicine and Journal of Polymer Science Part A Polymer Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact